Cindy Jacobs
2021
In 2021, Cindy Jacobs earned a total compensation of $1.1M as President and Chief Medical Officer at OncoGenex Pharmaceuticals, a 37% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $228,800 |
---|---|
Option Awards | $324,141 |
Salary | $440,000 |
Stock Awards | $65,450 |
Total | $1,058,391 |
Jacobs received $440K in salary, accounting for 42% of the total pay in 2021.
Jacobs also received $228.8K in non-equity incentive plan, $324.1K in option awards and $65.5K in stock awards.
Rankings
In 2021, Cindy Jacobs' compensation ranked 8,610th out of 12,415 executives tracked by ExecPay. In other words, Jacobs earned more than 30.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,610 | 31st |
Manufacturing | 3,814 | 31st |
Chemicals And Allied Products | 1,687 | 29th |
Drugs | 1,501 | 28th |
In Vitro and In Vivo Diagnostic Substances | 35 | 43rd |
Jacobs' colleagues
We found two more compensation records of executives who worked with Cindy Jacobs at OncoGenex Pharmaceuticals in 2021.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019